Thanks to these partners for supporting OWL at the highest level. Your contributions make it possible to bring life to our mission of Advancing Diversity in Leadership.
Employees of these partner organizations enjoy special membership privileges.
To find out more about being a partner, click here.
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.
Allergan’s success is powered by our global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.
With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.
As the global leader in eye care, Alcon develops and manufactures innovative medicines and devices to serve the full life cycle of eye care needs. Alcon’s one mission is to provide products that enhance the quality of life by helping people see better.
At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn.
Shire is the global biotechnology leader serving patients with rare diseases and specialized conditions. We seek to push boundaries through discovering and delivering new possibilities for patient communities across our portfolio of therapeutic areas including Immunology, Hematology, Genetic Diseases, Neuroscience, Internal Medicine, Ophthalmics, and Oncology.
ZEISS is one of the world’s leading suppliers of medical devices in the field of medical technology. It supplies innovative technologies and application-oriented solutions for ophthalmology and microsurgery designed to help doctors improve the quality of life of their patients.
Sponsors & Funders
Click here to learn more about becoming a partner/sponsor of OWL. OWL is grateful to these event, program and interest group sponsors who make our educational events possible.
Lexitas is a full-service clinical research organization specializing in ophthalmology. We are focused on providing both technical expertise and exceptional service to our sponsors. Lexitas is your clinical trial partner expert for clinical trial operations, study design, project management, clinical and medical monitoring, and site relations and training.
Lexitas understands our customer’s needs – The professionals at Lexitas have extensive clinical development experience in both the CRO and pharmaceutical company settings which allows us to fully understand the needs of our clients and how to meet these needs.
Lexitas brings solutions – Lexitas is 100% focused on executing ophthalmic clinical trials and understands this therapeutic area deeply. The Lexitas leadership team each has 20+ years of experience in clinical trial design and execution within the Ophthalmology space.
Lexitas has established site relationships – Lexitas believes the relationship with investigators and site staff is critical, and we treat our investigators as partners and clients. The way Lexitas interacts with sites helps us deliver exceptional results for the sponsor.